Literature DB >> 29397491

Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.

Krishma Kumar1, Mohammed Saadi1, Frederick V Ramsey1, Ron Schey1, Henry P Parkman2,3.   

Abstract

BACKGROUND: Small intestinal bacterial overgrowth (SIBO) may cause symptoms in patients with abdominal bloating, distension, and gas. SIBO can be assessed using the lactulose breath test (LBT). A commonly used probiotic supplement is Align containing Bifidobacterium infantis 35624. The aim of this study was to determine the effect of B. infantis 35624 on hydrogen and methane excretion during LBT.
METHODS: Healthy subjects underwent LBT before and after 2 weeks of daily Align administration. Hydrogen and methane concentrations were measured for each breath sample. Results are expressed as mean ± SE and analyzed using repeated measures ANCOVA. A breath test was considered positive if hydrogen and/or methane increased > 20 ppm above baseline by 90 min of the test or if a dual hydrogen peak was present.
RESULTS: Nineteen healthy subjects were studied. Hydrogen levels were similar pre- and post-probiotic across the 3-h study (p = 0.768). In contrast, methane levels were significantly higher with probiotic administration (p = 0.012). A rise in methane > 20 ppm was seen in three subjects pre-probiotic but six post-probiotic. Of the 19 subjects, an "abnormal" LBT pre-probiotic was present in ten subjects and during the probiotic, 13 were abnormal.
CONCLUSIONS: This study found that 2 weeks of B. infantis 35624 (Align) supplementation affects LBT assessment for SIBO by significantly increasing methane, but not hydrogen, excretion after lactulose administration. Methane levels reached values that would be considered positive for SIBO patients. This study suggests that patients undergoing LBT should discontinue probiotics prior to the test as these supplements may alter the test results.

Entities:  

Keywords:  Gastrointestinal microbiome; Lactulose breath test; Probiotics; Small intestinal bacterial overgrowth

Mesh:

Substances:

Year:  2018        PMID: 29397491     DOI: 10.1007/s10620-018-4945-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Do probiotics improve symptoms in patients with irritable bowel syndrome?

Authors:  Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.

Authors:  Richard J Saad; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 11.382

3.  Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.

Authors:  A M Rentz; P Kahrilas; V Stanghellini; J Tack; N J Talley; C de la Loge; E Trudeau; D Dubois; D A Revicki
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

4.  Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic.

Authors:  Duane Charbonneau; Roger D Gibb; Eamonn M M Quigley
Journal:  Gut Microbes       Date:  2013-04-02

Review 5.  How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.

Authors:  Ali Rezaie; Mark Pimentel; Satish S Rao
Journal:  Curr Gastroenterol Rep       Date:  2016-02

Review 6.  Gas and the microbiome.

Authors:  Mark Pimentel; Ruchi Mathur; Christopher Chang
Journal:  Curr Gastroenterol Rep       Date:  2013-12

7.  Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Authors:  Doron Boltin; Tsachi Tsadok Perets; Einav Shporn; Shoshana Aizic; Sigal Levy; Yaron Niv; Ram Dickman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-10-17       Impact factor: 3.944

Review 8.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

9.  Probiotic bacteria influence the composition and function of the intestinal microbiota.

Authors:  Paul W O'Toole; Jakki C Cooney
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-03

Review 10.  Clinical Uses of Probiotics.

Authors:  Saif Ul Islam
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  2 in total

Review 1.  Probiotics, Nutrition, and the Small Intestine.

Authors:  Taylor C Judkins; Douglas L Archer; Dean C Kramer; Rebecca J Solch
Journal:  Curr Gastroenterol Rep       Date:  2020-01-13

Review 2.  Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.

Authors:  Justyna Paulina Wielgosz-Grochowska; Nicole Domanski; Małgorzata Ewa Drywień
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.